Covidien kicks off PAD studies in Europe - masshightech.com - Western Massachusetts Economic Development Council

Covidien kicks off PAD studies in Europe

masshightech.com (Aug 8 2011) Health Care , Life Sciences
1. Covidien said its Definitive AR anti-restenosis study is enrolling patients at Imelda Hospital in Bonheiden, Belgium. Definitive AR is a pilot study designed to address restenosis, which is the narrowing of a blood vessel in patients with PAD, and will look at the impact of treating a diseased vessel with plaque excision prior to the use of a drug-coated balloon. The study will focus on whether removing calcified plaque will enhance the absorption of drugs delivered by a drug-coated balloon. (Read Full Article)
  
  Bookmark or Share this article
Login to comment
Related Articles
Massachusetts awards $660K to 'innovation schools'

also written by James M. Connolly

Microbe factory future pitched

also categorized in Life Sciences

Mass. invites cleantech fund requests - Mass High Tech Business News

also written by James M. Connolly

AIC in Springfield offers education incentives in hard times - MassLive.com

also categorized in Life Sciences

Covidien CFO positive on 2011 outlook | MassDevice - Medical Device Industry News

also mentions Covidien

Massachusetts Biotechnology Council gives Springfield high rating for companies looking to set up laboratories or factories

also categorized in Life Sciences

Internship website aims to keep students in Massachusetts

also written by James M. Connolly

MassDevelopment.com: Press Room: MassDevelopment Names New Brownfields Priority Project Communities: Boston, Chelmsford, New Bedford, Springfield Eligible for $2 Million Each to Remediate, Market Key Sites

also categorized in Life Sciences

Universities flood feds with stimulus grant proposals

also published in masshightech.com

Community colleges tackle tech education with federal help

also categorized in Life Sciences